RRAGC and cancer: Consistent with the apoptosis assay results (Figure 6E), we observed that the in vitro growth of cancer cells under amino acid stimulation was reduced by the knockdown of NRF3, SLC38A9, or RagC and by rapamycin treatments (Figure 7A).